Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

October 04, 2015 3:54 AM ET


Company Overview of Carmot Therapeutics, Inc.

Company Overview

Carmot Therapeutics, Inc. provides drugs to treat inflammatory, metabolic, and neurological diseases. The company was founded in 2008 and is based in San Francisco, California.

409 Illinois Streeet

San Francisco, CA 94158

United States

Founded in 2008



Key Executives for Carmot Therapeutics, Inc.

Co-Founder and Chief Executive Officer
Vice President of Business Development
Compensation as of Fiscal Year 2015.

Carmot Therapeutics, Inc. Key Developments

Carmot Therapeutics, Inc. Presents at BIO International Convention 2015, Jun-16-2015 03:00 PM

Carmot Therapeutics, Inc. Presents at BIO International Convention 2015, Jun-16-2015 03:00 PM. Venue: Pennsylvania Convention Center, Philadelphia, Pennsylvania, United States. Speakers: David V. Jobes, Vice President of Business Development.

Carmot Therapeutics, Inc. Presents at BIO International Convention, Jun-26-2014 10:00 AM

Carmot Therapeutics, Inc. Presents at BIO International Convention, Jun-26-2014 10:00 AM. Venue: San Diego Convention Center, San Diego, California, United States.

Carmot Therapeutics Names Dave Jobes, PhD as Vice President of Business Development

Carmot Therapeutics reported that Dave Jobes, PhD, has joined the company as vice president of business development. Jobes brings nearly 15 years of biopharmaceutical industry experience to Carmot from such diverse areas as diagnostics, vaccines, and small molecule therapeutics. Prior to joining Carmot, Jobes headed his own consulting firm focused on assisting clients with transactional work and business development strategies. Previously, he was co-founder and vice president of business development at Presidio Pharmaceuticals. Jobes will be leading the company's partnering efforts around its internal programs in diabetes and cancer, its proprietary lead-identification technology, Chemotype Evolution, and Tethering, to which Carmot has an exclusive license.

Similar Private Companies By Industry

Company Name Region
Alevium Pharmaceuticals Inc. United States
Dartmouth-Hitchcock Clinic United States
Thor Incorporated United States
Metagenics, Inc. United States
Biotecnol Pharmaceuticals, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Carmot Therapeutics, Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at